These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23895325)

  • 41. Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector.
    Mingozzi F; Schüttrumpf J; Arruda VR; Liu Y; Liu YL; High KA; Xiao W; Herzog RW
    J Virol; 2002 Oct; 76(20):10497-502. PubMed ID: 12239326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.
    Katwal AB; Konkalmatt PR; Piras BA; Hazarika S; Li SS; John Lye R; Sanders JM; Ferrante EA; Yan Z; Annex BH; French BA
    Gene Ther; 2013 Sep; 20(9):930-8. PubMed ID: 23535898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of an adeno-associated virus serotype Anc80 to provide durable cure of phenylketonuria in a mouse model.
    Kaiser RA; Weber ND; Trigueros-Motos L; Allen KL; Martinez M; Cao W; VanLith CJ; Hillin LG; Douar A; González-Aseguinolaza G; Aldabe R; Lillegard JB
    J Inherit Metab Dis; 2021 Nov; 44(6):1369-1381. PubMed ID: 33896013
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
    Schön C; Biel M; Michalakis S
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.
    Della Peruta M; Badar A; Rosales C; Chokshi S; Kia A; Nathwani D; Galante E; Yan R; Arstad E; Davidoff AM; Williams R; Lythgoe MF; Nathwani AC
    Hum Gene Ther; 2015 Feb; 26(2):94-103. PubMed ID: 25569358
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adeno-associated virus-mediated delivery of glial cell line-derived neurotrophic factor protects motor neuron-like cells from apoptosis.
    Keir SD; Xiao X; Li J; Kennedy PG
    J Neurovirol; 2001 Oct; 7(5):437-46. PubMed ID: 11582516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
    Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
    Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9-dependent innate immune responses in the liver.
    Martino AT; Suzuki M; Markusic DM; Zolotukhin I; Ryals RC; Moghimi B; Ertl HC; Muruve DA; Lee B; Herzog RW
    Blood; 2011 Jun; 117(24):6459-68. PubMed ID: 21474674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient trans-splicing in the retina expands the utility of adeno-associated virus as a vector for gene therapy.
    Reich SJ; Auricchio A; Hildinger M; Glover E; Maguire AM; Wilson JM; Bennett J
    Hum Gene Ther; 2003 Jan; 14(1):37-44. PubMed ID: 12573057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficient whole-body transduction with trans-splicing adeno-associated viral vectors.
    Ghosh A; Yue Y; Long C; Bostick B; Duan D
    Mol Ther; 2007 Apr; 15(4):750-5. PubMed ID: 17264855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimization of self-complementary AAV vectors for liver-directed expression results in sustained correction of hemophilia B at low vector dose.
    Wu Z; Sun J; Zhang T; Yin C; Yin F; Van Dyke T; Samulski RJ; Monahan PE
    Mol Ther; 2008 Feb; 16(2):280-9. PubMed ID: 18059373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
    Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alpha-1-Antitrypsin Promoter Improves the Efficacy of an Adeno-Associated Virus Vector for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy.
    Cabrera-Pérez R; Vila-Julià F; Hirano M; Mingozzi F; Torres-Torronteras J; Martí R
    Hum Gene Ther; 2019 Aug; 30(8):985-998. PubMed ID: 30900470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement of Adeno-Associated Virus-Mediated Liver Transduction Efficacy by Regional Administration in Macaca fascicularis.
    Zabaleta N; Salas D; Paramo M; Hommel M; Sier-Ferreira V; Hernandez-Alcoceba R; Prieto J; Bilbao JI; Gonzalez-Aseguinolaza G
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):68-73. PubMed ID: 28285544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AAV-PGIS gene transfer improves hypoxia-induced pulmonary hypertension in mice.
    Kawakami T; Kanazawa H; Satoh T; Ieda M; Ieda Y; Kimura K; Mochizuki H; Shimada T; Yokoyama C; Ogawa S; Tanabe T; Fukuda K
    Biochem Biophys Res Commun; 2007 Nov; 363(3):656-61. PubMed ID: 17904526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safe and Sustained Expression of Human Iduronidase After Intrathecal Administration of Adeno-Associated Virus Serotype 9 in Infant Rhesus Monkeys.
    Hordeaux J; Hinderer C; Buza EL; Louboutin JP; Jahan T; Bell P; Chichester JA; Tarantal AF; Wilson JM
    Hum Gene Ther; 2019 Aug; 30(8):957-966. PubMed ID: 31017018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2/8 vector-mediated gene therapy in murine phenylketonuria.
    Harding CO; Gillingham MB; Hamman K; Clark H; Goebel-Daghighi E; Bird A; Koeberl DD
    Gene Ther; 2006 Mar; 13(5):457-62. PubMed ID: 16319949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
    Grimm D; Kay MA
    Curr Gene Ther; 2003 Aug; 3(4):281-304. PubMed ID: 12871018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.